We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

74 hedge funds and large institutions have $270M invested in Avadel Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

67.42% more ownership

Funds ownership: 0% → 67.42% (+67%)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

3% less funds holding

Funds holding: 76 → 74 (-2)

6% less capital invested

Capital invested by funds: $286M → $270M (-$15.9M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
16
Increased
18
Reduced
19
Closed
16
Calls
$131K
Puts
–
Net Calls
+$131K
Net Calls Change
+$217K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$9.97M
2
BlackRock
BlackRock
New York
+$5.44M
3
SCM
Stonepine Capital Management
Oregon
+$4.26M
4
HA
Heartland Advisors
Wisconsin
+$1.88M
5
GCP
GSA Capital Partners
United Kingdom
+$1.82M

Top Sellers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
-$5.97M
2
Deutsche Bank
Deutsche Bank
Germany
-$4.12M
3
KFA
Kelleher Financial Advisors
New York
-$2.01M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.3M
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$1.43M +$1.47M +147,419 New
B
27
Bailard
California
$1.36M +$1.41M +141,000 New
CS
28
Candriam SCA
Luxembourg
$1.07M +$1.11M +111,000 New
DMK
29
David M. Knott
$964K – – –
SCM
30
Sio Capital Management
New York
$885K – – –
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$818K -$37K -3,700 -4%
COPPSERS
32
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$754K – – –
Goldman Sachs
33
Goldman Sachs
New York
$745K -$40K -3,996 -5%
Stifel Financial
34
Stifel Financial
Missouri
$561K – – –
CCI
35
Columbus Circle Investors
$424K -$54.9K -5,493 -11%
Ohio Public Employees Retirement System (OPERS)
36
Ohio Public Employees Retirement System (OPERS)
Ohio
$407K – – –
EVM
37
Eaton Vance Management
Massachusetts
$336K +$347K +34,700 New
State of New Jersey Common Pension Fund D
38
State of New Jersey Common Pension Fund D
New Jersey
$319K – – –
Bank of America
39
Bank of America
North Carolina
$317K +$10.6K +1,062 +3%
SGAM
40
Smith Group Asset Management
Texas
$315K – – –
State Street
41
State Street
Massachusetts
$302K +$8.58K +858 +3%
Geode Capital Management
42
Geode Capital Management
Massachusetts
$302K +$313K +31,263 New
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$232K +$239K +23,947 New
TI
44
Trexquant Investment
Connecticut
$226K +$110K +11,031 +90%
ProShare Advisors
45
ProShare Advisors
Maryland
$209K -$50.8K -5,078 -19%
CG
46
Cutler Group
California
$203K – – –
CCM
47
Condor Capital Management
New Jersey
$163K – – –
Northern Trust
48
Northern Trust
Illinois
$155K +$160K +16,009 New
US Bancorp
49
US Bancorp
Minnesota
$121K – – –
Citigroup
50
Citigroup
New York
$116K – – –
1
2
3 4

AVDL Hedge Fund Activity: Q1 2017 in Review

74 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2017, worth a combined $270M — down 5.6% from $286M a quarter earlier.

Fund positioning in AVDL was balanced in Q1 2017: 16 funds opened new positions, 16 closed out, 18 added to existing stakes and 19 trimmed.

The largest buyer was J. Goldman & Co, opening a new position worth an estimated $9.97M. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $5.97M sold.

  • 74 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2017, down from 76 in Q4 2016.
  • Funds reported $270M of Avadel Pharmaceuticals stock for Q1 2017, down 5.6% quarter-over-quarter.
  • 16 funds opened new Avadel Pharmaceuticals positions in Q1 2017 and 16 closed out, a net change of 0 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2017 was J. Goldman & Co, an estimated $9.97M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2017 was Ghost Tree Capital, an estimated $5.97M sold.

Based on aggregated 13F filings for Q1 2017.